SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MEDX ... anybody following?
MEDX 31.15-0.3%Nov 3 1:15 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: rkrw who wrote (2106)1/13/2009 3:05:38 PM
From: LJM  Read Replies (1) of 2240
 
Somebody must have made a typo. ;-)

Medarex expects a cash burn rate per month of ~$12.2 mln, a decrease from previous guidance for a monthly 2008 cash burn rate of ~$12.4 mln

12:11 PM ET 1/13/09 | Briefing.com


For FY08, co currently expects a cash burn rate per month of ~$12.2 mln, a decrease from previous guidance for a monthly 2008 cash burn rate of ~$12.4 mln. This guidance includes Medarex's continual investment in its pipeline and the net contributions to the ipilimumab program. Medarex expects its monthly cash burn rate per month for the full year of 2009 to remain largely consistent with full-year 2008 net cash burn.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext